Rishi Nayyar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rishi Nayyar has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Amlesh Seth
Department of Urology, All India Institute of Medical Sciences, New Delhi, India
11 shared publications - Brusabhanu Nayak
Department of Urology, All India Institute of Medical Sciences, New Delhi, India
8 shared publications - Rajeev Kumar
Department of Urology All India Institute of Medical Sciences New Delhi India
8 shared publications Amlesh Seth
7 shared publications- Prabhjot Singh
Department of Urology, Penn State Milton S. Hershey Medical Center, Hershey, USA
7 shared publications Prabhjot Singh
Department of Urology, All India Institute of Medical Sciences, New Delhi, India
6 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 101
Single-dose/day versus extended antibiotic prophylaxis for elective urological surgery: a prospective randomized controlled trial
- 29 October 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 101
Open AccessSingle-dose/day versus extended antibiotic prophylaxis for elective urological surgery: a prospective randomized controlled trial
- Open Access
- 29 September 2026
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 42 (4) , 259-261
Non-urinary tract infection antibiotic prescription and precision medicine
Was not provided for this article.
- 29 September 2026
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 42 (4) , 259-261
Open AccessNon-urinary tract infection antibiotic prescription and precision medicine
Was not provided for this article.
- 4 May 2026
- Published by SAGE Publications in Journal of Clinical Urology
Rectourethral fistula: Surgical approaches and insights from our experience and literature review
Objectives: To present our experience and outcomes in the surgical management of rectourethral fistula (RUF). Materials and methods: We retrospectively analysed data from 11 patients treated for RUF between 2015 and 2024. Patient demographics, aetiology, fistula complexity, surgical approach, and outcomes were reviewed. Results: The mean patient age was 29 years (range = 18–62). In 81% of cases, RUF resulted from road traffic accidents, and four patients had previously failed repairs. All patients underwent suprapubic catheter placement and faecal diversion before definitive surgery. Seven patients (63.6%) had a complex fistulas, while four had simple ones. The perineal approach was used in eight patients (72.7%), with a transpubic in two patients (18.18%) and cystectomy with ileal conduit diversion in one patient (9%). The gracilis muscle interposition flap was used in most cases. At a 1-year follow-up, no patients experienced per rectal leakage, and 81% had catheter removal by 3 months. Conclusion: Our study demonstrates that with thorough evaluation and proper management, RUF closure rates can reach up to 100%. The pedicled gracilis muscle flap is highly effective for interposition in complex cases. Level of evidence: 2c
- 4 May 2026
- Published by SAGE Publications in Journal of Clinical Urology
Rectourethral fistula: Surgical approaches and insights from our experience and literature review
Objectives: To present our experience and outcomes in the surgical management of rectourethral fistula (RUF). Materials and methods: We retrospectively analysed data from 11 patients treated for RUF between 2015 and 2024. Patient demographics, aetiology, fistula complexity, surgical approach, and outcomes were reviewed. Results: The mean patient age was 29 years (range = 18–62). In 81% of cases, RUF resulted from road traffic accidents, and four patients had previously failed repairs. All patients underwent suprapubic catheter placement and faecal diversion before definitive surgery. Seven patients (63.6%) had a complex fistulas, while four had simple ones. The perineal approach was used in eight patients (72.7%), with a transpubic in two patients (18.18%) and cystectomy with ileal conduit diversion in one patient (9%). The gracilis muscle interposition flap was used in most cases. At a 1-year follow-up, no patients experienced per rectal leakage, and 81% had catheter removal by 3 months. Conclusion: Our study demonstrates that with thorough evaluation and proper management, RUF closure rates can reach up to 100%. The pedicled gracilis muscle flap is highly effective for interposition in complex cases. Level of evidence: 2c
- Open Access
- 29 January 2025
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 41 (2) , 148-150
A novel method of using indocyanine green fluorescence technique for nephron-sparing surgery
Two complex small renal masses were operated using a novel method of utilising indocyanine green fluorescence for nephron-sparing surgery (NSS), overcoming its current limitations of short duration of effect and non-enhancement of the tumor. The dye was emulsified with ethiodized oil and a 1:1 mixture was administered on the morning of the surgery using superselective cannulation of the direct tumoral blood supply. The fluorescence could be used throughout the entire course of the surgery irrespective of arterial clamping, allowing quick tumor identification, edge marking, and near-enucleation over enucleoresection. This novel method has the potential to aid the surgeon during various critical steps of NSS.
- 29 January 2025
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 41 (2) , 148-150
Open AccessA novel method of using indocyanine green fluorescence technique for nephron-sparing surgery
Two complex small renal masses were operated using a novel method of utilising indocyanine green fluorescence for nephron-sparing surgery (NSS), overcoming its current limitations of short duration of effect and non-enhancement of the tumor. The dye was emulsified with ethiodized oil and a 1:1 mixture was administered on the morning of the surgery using superselective cannulation of the direct tumoral blood supply. The fluorescence could be used throughout the entire course of the surgery irrespective of arterial clamping, allowing quick tumor identification, edge marking, and near-enucleation over enucleoresection. This novel method has the potential to aid the surgeon during various critical steps of NSS.
- 11 January 2025
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 43 (5) , 331.e9-331.e16
Immediate second resection versus restage transurethral resection of bladder tumor: A prospective randomized clinical trial (IMMERSE trial)
- 11 January 2025
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 43 (5) , 331.e9-331.e16
Immediate second resection versus restage transurethral resection of bladder tumor: A prospective randomized clinical trial (IMMERSE trial)
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 41 (1) , 1-2
Neoadjuvant chemotherapy for bladder cancer: Two decades on
- 1 January 2025
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 41 (1) , 1-2
Open AccessNeoadjuvant chemotherapy for bladder cancer: Two decades on
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 41 (1) , 69-72
Urethral duplication with five openings in anal canal: A novel case report
Urethral duplication is a rare congenital anomaly characterized by more than one urethral channel, with varied course, location of the external opening, and presentation. Presentations can be varied, depending upon individual anatomical dispensation but mostly present as obstruction, recurrent urinary infection, or double urinary stream. Treatment depends on the type of duplication and associated anomalies. Here, we report a case of urethral duplication which did not fit into any known reported type of urethral duplication forms and had five openings at the anal verge.
- 1 January 2025
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 41 (1) , 69-72
Open AccessUrethral duplication with five openings in anal canal: A novel case report
Urethral duplication is a rare congenital anomaly characterized by more than one urethral channel, with varied course, location of the external opening, and presentation. Presentations can be varied, depending upon individual anatomical dispensation but mostly present as obstruction, recurrent urinary infection, or double urinary stream. Treatment depends on the type of duplication and associated anomalies. Here, we report a case of urethral duplication which did not fit into any known reported type of urethral duplication forms and had five openings at the anal verge.
- 10 May 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 15 (3) , 563-571
Comparative Analysis of Clinicopathologic Characteristics and Outcomes of Urothelial Bladder Cancer Between Young and Older Adults—Experience from a Tertiary Care Center
The evidence on bladder cancer in the young population remains fragmented due to lack of literature and conflicting results from the existing studies. We aim to elucidate such conflicting data and define the clinicopathologic characteristics, management trends, and outcomes of urothelial bladder carcinoma in young adults as compared to their older counterparts. This was a retrospective, single-center study involving patients with primary urothelial bladder cancer who underwent treatment at our center from March 2017 to March 2022. For analysis, patients were stratified into three subgroups based on age: group A, 18–40 years; group B, > 40 years; and group C, > 60 years. Group A with younger patients was compared with groups B and C. A total of 471 eligible patients (422 males and 49 females) were included in the study with a median age of 44 years. Group A had significantly lower recurrence and progression rates as compared to group B (31% vs 57.1%, p = 0.002 and 9.5% vs 19.2%, p = 0.04, respectively). Group A had significantly more recurrence-free survival (RFS) than group B (5-year-RFS = 68.03% vs 32.58%, p = 0.01). Similarly, group A also had lower recurrence (31% vs 62.6%, p < 0.001) and progression (9.5% vs 28.6%, p = 0.015) rates as compared to group C as well as better RFS (5-year-RFS = 68.03% vs 19.00%, p = 0.04) and progression-free survival (5-year-PFS = 83.1% vs 62.8%, p = 0.03) in comparison to group C. Age and tumor grade were found to be independent predictors of recurrence-free and progression-free survival. We concluded that high-grade disease is more common than low-grade disease both in younger and older patients. Younger patients fare better in terms of recurrence and progression when compared to their older counterparts.
- 10 May 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 15 (3) , 563-571
Comparative Analysis of Clinicopathologic Characteristics and Outcomes of Urothelial Bladder Cancer Between Young and Older Adults—Experience from a Tertiary Care Center
The evidence on bladder cancer in the young population remains fragmented due to lack of literature and conflicting results from the existing studies. We aim to elucidate such conflicting data and define the clinicopathologic characteristics, management trends, and outcomes of urothelial bladder carcinoma in young adults as compared to their older counterparts. This was a retrospective, single-center study involving patients with primary urothelial bladder cancer who underwent treatment at our center from March 2017 to March 2022. For analysis, patients were stratified into three subgroups based on age: group A, 18–40 years; group B, > 40 years; and group C, > 60 years. Group A with younger patients was compared with groups B and C. A total of 471 eligible patients (422 males and 49 females) were included in the study with a median age of 44 years. Group A had significantly lower recurrence and progression rates as compared to group B (31% vs 57.1%, p = 0.002 and 9.5% vs 19.2%, p = 0.04, respectively). Group A had significantly more recurrence-free survival (RFS) than group B (5-year-RFS = 68.03% vs 32.58%, p = 0.01). Similarly, group A also had lower recurrence (31% vs 62.6%, p < 0.001) and progression (9.5% vs 28.6%, p = 0.015) rates as compared to group C as well as better RFS (5-year-RFS = 68.03% vs 19.00%, p = 0.04) and progression-free survival (5-year-PFS = 83.1% vs 62.8%, p = 0.03) in comparison to group C. Age and tumor grade were found to be independent predictors of recurrence-free and progression-free survival. We concluded that high-grade disease is more common than low-grade disease both in younger and older patients. Younger patients fare better in terms of recurrence and progression when compared to their older counterparts.